您的位置: 首页 > 农业专利 > 详情页

SUBSTITUTED THIAZOLES OR OXAZOLES AS P2X7 RECEPTOR ANTAGONISTS
专利权人:
AXXAM S.P.A.
发明人:
PEVARELLO Paolo (IT),ПЕВАРЕЛЛО Паоло (IT),LOHMER Stefan (IT),ЛОМЕР Стефан (IT),LIBERATI Chiara (IT),ЛИБЕРАТИ Кьяра (IT),SENECI Pierfausto (IT),СЕНЕЧИ Пьерфаусто (IT),PESENTI Cristina (IT),ПЕСЕНТИ Крис
申请号:
RU2016131689
公开号:
RU0002701858C1
申请日:
2015.02.04
申请国别(地区):
RU
年份:
2019
代理人:
摘要:
FIELD: medicine; pharmaceuticals.SUBSTANCE: invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, including any stereochemically isomeric form thereof, where n equals 1 or 2; Y is oxygen or sulphur; each of R1 and R2 is independently selected from a group consisting of hydrogen, deuterium, C1-C4alkyl optionally substituted with hydroxy or halogen, such as hydroxymethyl, fluoromethyl, difluoromethyl, trifluoromethyl, C3-C6cycloalkyl optionally substituted with hydroxy or halogen, or C1-C4alkyloxy; each of R3 and R4 is independently selected from a group consisting of hydrogen, halogen, C1-C4alkyl, C1-C4alkyloxy, NR9R10, where R9 and R10 independently represent hydrogen or C1-C4alkyl, or 1,2-thiazolidine-1,1-dione; or two groups R3 or group R3 and R4 together form a six-member heterocyclic ring containing a nitrogen atom; R5 is selected from hydrogen, halogen or represents a heterocyclic ring selected from pyrimidin-2-yl, pyridin-2-yl or pyrazin-2-yl optionally substituted with halogen, C1-C4alkyl; R7 is hydrogen or C1-C4alkyl; radical of formula (a) is optionally substituted azetidine, piperidine, morpholine, oxazepane or 1,2,3,4-tetrahydroisoquinoline ring, where each of R6 is independently selected from a group consisting of hydrogen, halogen, C3-C6 spirocycloalkyl, phenyl, pyrazolyl, phenoxy or benzyloxy, where the phenyl or pyrazolyl group is optionally substituted with halogen, C1-C4alkyl, fluoromethyl, difluoromethyl, trifluoromethyl., (a).EFFECT: compounds of formula (I) have P2X7 receptor antagonist properties.15 cl, 1 dwg, 2 tbl, 26 exИзобретение относится к соединению формулы (I) или его фармацевтически приемлемой соли, включая их любую стереохимически изомерную форму, где n равно 1 или 2; Y представляет собой кислород или серу; каждый из R1 и R2 независимо выбран из группы, состоящей из водорода, дейтерия, С1-С4алкила, возможно замещенного гидрокси или галогеном, такого как гидроксиметил, фторметил, дифторметил, три
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充